Quick search
Advanced search in
Field to searchTerm
Add rule
Download Results
8 research outcomes, page 1 of 1
  • publication . Article . 2020
    Open Access Russian
    Persistent Identifiers
    Publisher: «FIRMA «SILICEA» LLC 

    # This guidelines is current as of 01.04.2020. Follow the information updates on the website of the Russian Society of Cardiology www.scardio.ru

    Add to ORCID
  • publication . Article . 2020
    Open Access Russian
    Persistent Identifiers
    Publisher: «FIRMA «SILICEA» LLC 

    History of heart transplantation in combination with immunosuppressive therapy and acute viral respiratory infection overlay makes the patient difficult to manage. In case of COVID-19, the setting is complicated by unknown pathogenesis, including its effect on blood, co...

    Add to ORCID
  • publication . Article . 2020
    Open Access Russian
    Authors:
    A.M. Namitokov; O.P. Ishevskaya; V.I. Fetisova; E D Kosmacheva; V.A. Porkhanov;
    Persistent Identifiers
    Publisher: «FIRMA «SILICEA» LLC 

    <jats:p>The novel coronavirus infection COVID-19 pandemic has spread to more than 180 countries. Cardiovascular patients belong to one of the susceptible population cohorts. There is a peculiar pathogenesis and variety of clinical manifestations of COVID-19, as well as ...

    Add to ORCID
  • publication . Article . 2020
    Open Access
    Authors:
    Alexandra Konradi; A. O. Nedoshivin;
    Persistent Identifiers
    Publisher: Silicea - Poligraf, LLC

    <jats:p>The article describes current data on the relationship of renin-angiotensin system and related drugs with the risk of COVID-19 infection and its outcomes. Analysis of the latest publications did not reveal association of angiotensin-converting enzyme inhibitors ...

    Add to ORCID
  • publication . Article . 2020
    Open Access
    Authors:
    E. V. Shlyakhto; E. V. Parmon; E. R. Berngardt; E. S. Zhabina;
    Persistent Identifiers
    Publisher: Silicea - Poligraf, LLC

    The ongoing pandemic caused by virus SARS-CoV-2 encourages the search for ways to save the population. Since people first encountered this disease, it is being actively studied, and updating medical information is extremely valuable. Since people first encountered this ...

    Add to ORCID
  • <jats:p>С целью получения экспертного мнения по вопросам, связанным с актуальностью, протоколами и режимами антитромботической терапии у пациентов с COVID-19 на госпитальном и амбулаторном этапах лечения 25 июля 2020г была проведена Международная он-лайн встреча эксперт...

    Add to ORCID
  • publication . Article . 2020
    Open Access
    Authors:
    O. V. Blagova; N. V. Varionchik; V. A. Zaydenov; P. O. Savina; N. D. Sarkisova;
    Persistent Identifiers
    Publisher: Silicea - Poligraf, LLC

    <jats:p>The level and significance of anticardiac antibodies (ACA) in patients with COVID-19 infection have not yet been studied.<jats:bold>Aim</jats:bold>. To assess the level of various ACA in patients with severe and moderate COVID-19 infection and to identify the co...

    Add to ORCID
  • publication . Article . 2020
    Open Access
    Authors:
    G. P. Arutyunov; E. I. Tarlovskaya; A. G. Arutyunov; Y. N. Belenkov; A. O. Konradi; Y. M. Lopatin; S. N. Tereshchenko; A. P. Rebrov; A. I. Chesnikova; I. V. Fomin; ...
    Persistent Identifiers
    Publisher: Silicea - Poligraf, LLC

    <jats:p>COVID-19 is a severe infection with high mortality. The concept of the disease has been shaped to a greater extent on the basis of large registers from the USA, Spain, Italy, and China. However, there is no information on the disease characteristics in Caucasian...

    Add to ORCID
8 research outcomes, page 1 of 1